期刊文献+

液基细胞学联合HPV mRNA检测对宫颈癌的诊断价值 被引量:36

Clinical value of combination of HPV E6/E7 mRNA assay and thinprep cytologic test assay in screening of cervical cancer
下载PDF
导出
摘要 目的:探索高危型HPV E6/E7 mRNA和HPV E6/E7 DNA两种检测方法分别联合宫颈薄层液基细胞学检查(TCT)应用于宫颈癌早期诊断的临床意义。方法:选择2013年1月至2014年12月我院妇科门诊就诊行TCT检查的259例检测标本,对高危型HPV E6/E7 mRNA和HPV E6/E7 DNA进行检测,结合xb细胞病理学分级和组织病理学诊断进行统计分析。结果:纳入研究的259例患者中HPV E6/E7 mRNA检测阳性率为35.1%(91/259),HPV E6/E7 DNA检测阳性率为52.1%(135/259)。NILM、ASCUS、LSIL、HSIL四种细胞病理学分级HPV E6/E7 mRNA和HPV E6/E7 DNA检出率分别为23.5%、29.4%、64.3%、66.7%和32.4%、52.5%、61.9%、83.3%。对于正常组织,HPV E6/E7 mRNA的敏感度、准确度和阳性预测值均低于HPV E6/E7 DNA(P<0.05),但特异度和阴性预测值高于HPV E6/E7 DNA(P<0.001)。对于CIN1组织,HPV E6/E7 mRNA的敏感度、特异度和阳性预测值均低于HPV E6/E7 DNA(P<0.05),但准确度和阴性预测值高于HPV E6/E7 DNA(P<0.001)。在CIN2和CIN3组织中,HPV E6/E7 mRNA的准确度和阴性预测值均高于HPV E6/E7 DNA(P<0.001),HPV E6/E7 mRNA的敏感度、特异度、阳性预测值与HPV E6/E7 DNA无统计学差异(P>0.05)。结论:高危型HPV E6/E7 mRNA检测能更准确地反映病毒感染后的活化状态,HPV宫颈薄层液基细胞学检查联合高危型HPV E6/E7 mRNA检测可提高宫颈癌早期筛查的准确性。 Objective:To assess the clinical value of combination of HPV E6/E7 mRNA assay and thinprep cytologic test assay in screening of cervical cancer. Methods: Exfoliative cervical cells samples were collected from 259 women which carried cervical cancer screening by liquid based thinprep cytology test (TCT). Both the HPV E6/E7 mRNA assay and the HPV E6/E7 DNA assay were examined at the same time. The HPV E6/E7 mRNA assay were performed by branch - DNA (bDNA) technology. The HPV E6/E7 DNA assay were detected by HibriMax HPV - DNA genotyping. The data according to cytological pathology and histological pathology were analyzed. Results: The positive rates of HPV E6/E7 mRNA and HPV E6/E7 DNA were 34.7% (90/259) and 52.1% (135/259). The HPV E6/E7 mRNA positive rates for NILM, ASCUS, LSIL, HSIL were 23.5% ,29.4% ,64.3% ,66.7% respectively, and the HPV E6/E7 DNA positive rates for NILM, ASCUS, LSIL, HSIL were 32.4% ,52.5% ,61.9% ,83.3% respectively. In normal cervical tissues, the sensitivity, accuracy, positive predictive value of HPV E6/E7 mRNA were lower than the ones of HPV E6/E7 DNA ( P 〈 0.05 ), and specificity, negative predictive value of HPV E6/E7 mRNA was higher than the ones of HPV E6/E7 DNA ( P 〈 0. 001 ). In CIN1 tissues, the sensitivity, specificity and positive predictive value of HPV E6/E7 mRNA were lower than the ones of HPV E6/E7 DNA ( P 〈 0. 05 ) , and accuracy, negative predicative value of HPV E6/E7 mRNA were higher than HPV E6/E7 DNA ( P 〈 0.001 ). In CIN2 and CIN3 tissues, the accuracy, negative predicative value of HPV E6/E7 mRNA were higher than the ones of HPV E6/E7 DNA (P 〈 0.001 ). While there was no difference between the sensitivity, specificity, positive predicative value of HPV E6/ E7 mRNA and the ones of HPV E6/E7 DNA ( P 〉 0.05). Conclusion : The HPV E6/E7 mRNA assay can reflect the HPV infections leading to cellular transformation. The combination of the HPV E6/E7 mRNA assay and thinprep cytologic test assay is more specific than HPV E6/E7 DNA in triage of women in detection of cervical cancer.
出处 《现代肿瘤医学》 CAS 2016年第1期118-122,共5页 Journal of Modern Oncology
基金 国家自然科学基金项目(编号:81302243 81172458) 陕西省自然科学基金项目(编号:2014JM4157) 解放军第323医院培育课题(编号:2012323B14)
关键词 HPVE6/E7mRNA HPVE6/E7DNA 宫颈薄层液基细胞学检查 宫颈癌 HPV E6/E7 mRNA, HPV E6/E7 DNA, thinprep cytologic test assay, cervical cancer
  • 相关文献

参考文献16

  • 1M Goozner. Expanding cancer prevention and treatment in the de- veloping world [ J ]. J National Cancer Institute ,2012,104 (6) :432 - 433.
  • 2C Zhao, RM Austin. Human papillomavirus DNA detection in Thin- Prep Pap test vials is independent of cytologic sampling of thetransformation zone [ J ]. Gynecol Onco1,2007,107 ( 2 ) :231 - 235.
  • 3AA Renshaw, B Dubray Benstein ,J Haja, et al. Cytologic features of low- grade squamous intraepithelial lesion in thinprep papanicola- ou test slides and conventional smears: Comparison of cases that performed poorly with those that performed well in the College of A- merican Pathologists Interlaboratory Comparison Program in Cervi- coyaginal Cytology [ J ]. Archives of Pathol Lab Med, 2005,129 (1) :23 -25.
  • 4O Iwanari, K Yoshino. Cervical cancer screening using HPV DNA testing and cytology[ J]. Jap J Clin Med,2012,70 ( Suppl 4 ) : 139 - 143.
  • 5GA Boulet,IM Micalessi, CA Horvath, et al. Nucleic acid sequence -based amplification assay for human papillomavirus mRNA de- tection and typing:Evidence for DNA amplification[ J]. J Clin Mi- crobio1,2010 ,48 ( 7 ) :2524 - 2529.
  • 6M Benevolo,A Vocaturo, D Caraceni, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test[ J]. J Clin Microbio1,2011,49 (7) :2643 - 2650.
  • 7SG Lapierre, P Sauthier, MH Mayrand, et al. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of un- detemfined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high - grade lesions of the uterine ceivix [ J ]. J Clin Microbiol, 2012,50 ( 4 ) : 1240 - 1244.
  • 8S Dufresne, P Sauthier, MH Mayrand, et al. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of un- determined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high - grade lesions of the uterine cervix [ J ]. J Clin Microbio1,2011,49 ( 1 ) :48 - 53.
  • 9D Subramanya,PD Grivas. HPV and cervical cancer: Updates on an established relationship [ J ]. Postgraduate Med,2008,120 ( 4 ) : 7 - 13.
  • 10P Jiang,Y Yue. Human papillomavirus oncoproteins and apoptosis (Review) [ J ]. Exp Therapeutic Med, 2014,7 (1) : 3 - 7.

同被引文献252

引证文献36

二级引证文献281

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部